Vident Advisory’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,528
Closed -$179K 1532
2024
Q2
$179K Buy
+16,528
New +$179K 0.01% 1311